by Kelsey Barcomb | Mar 25, 2020
On March 18, 2020, the U.S. Food and Drug Administration (FDA) issued a Guidance Document for sponsors, investigators and institutional review boards (IRBs) conducting clinical trials during the coronavirus (COVID-19) pandemic. The purpose of this Alert is...
